[go: up one dir, main page]

RS50013B - Himerni gen koji kodira antigene determinante četiri proteina l.infantum - Google Patents

Himerni gen koji kodira antigene determinante četiri proteina l.infantum

Info

Publication number
RS50013B
RS50013B YUP-516/01A YU51601A RS50013B RS 50013 B RS50013 B RS 50013B YU 51601 A YU51601 A YU 51601A RS 50013 B RS50013 B RS 50013B
Authority
RS
Serbia
Prior art keywords
infantum
proteins
gene encoding
chimeric gene
antigenic determinants
Prior art date
Application number
YUP-516/01A
Other languages
English (en)
Inventor
Alonso Carlos Bedate
Original Assignee
C.B.F. Leti S.A.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C.B.F. Leti S.A., filed Critical C.B.F. Leti S.A.,
Publication of YU51601A publication Critical patent/YU51601A/sh
Publication of RS50013B publication Critical patent/RS50013B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Protein, naznačen time, što (a) ima aminokiseinsku sekvencu kao što je dato u SEQ ID No.1 ili (b) ima najmanje 90% identičnih amino kiselina sa aminokiselinskom sekvencom u SEQ ID No.1 i koja generiše imuni odgovor na leišmanijazu kod ljudi ili životinja. Prijava ima14 nezavisnih i 7 zavisnih zahteva.
YUP-516/01A 1998-12-23 1999-12-23 Himerni gen koji kodira antigene determinante četiri proteina l.infantum RS50013B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11382598P 1998-12-23 1998-12-23
CA2256124A CA2256124C (en) 1998-12-23 1998-12-23 Chimeric gene formed of the dna sequences that encode the antigenic determinants of four proteins of l. infantum, and protein encoded by said gene, and pharmaceutical composition useful for preventing and/or treating leishmaniosis in animals or humans

Publications (2)

Publication Number Publication Date
YU51601A YU51601A (sh) 2005-07-19
RS50013B true RS50013B (sr) 2008-09-29

Family

ID=27671952

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-516/01A RS50013B (sr) 1998-12-23 1999-12-23 Himerni gen koji kodira antigene determinante četiri proteina l.infantum

Country Status (5)

Country Link
JP (1) JP4883839B2 (sr)
BR (1) BRPI9917863B8 (sr)
CA (1) CA2256124C (sr)
RS (1) RS50013B (sr)
ZA (1) ZA200105994B (sr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2638062T3 (pl) * 2010-11-10 2018-11-30 Laboratorios Leti, S.L. Nowy adiuwant

Also Published As

Publication number Publication date
JP4883839B2 (ja) 2012-02-22
ZA200105994B (en) 2002-07-22
BRPI9917863C1 (pt) 2021-05-25
BRPI9917863A2 (sr) 2010-12-21
CA2256124A1 (en) 2000-06-23
CA2256124C (en) 2015-06-16
YU51601A (sh) 2005-07-19
BRPI9917863B1 (pt) 2016-08-02
BRPI9917863B8 (pt) 2022-08-30
JP2002533474A (ja) 2002-10-08

Similar Documents

Publication Publication Date Title
DK0587780T3 (da) Smitstof, som forårsager Mystery Swine Disease, vaccinepræparater og diagnostiske sæt
YU47735B (sh) Postupak za sintezu biološki aktivnih polipeptida limfotoksina
RS51157B (sr) Baff receptor (bcma), imunoregulatorni agens
DK532184A (da) Antigene aminosyresekvenser
EA200100447A1 (ru) Гибридные белки на основе бета-интерферона и их применение
ATE264691T1 (de) Newcastle-krankheitsvirus-kombinationsimpfstoff
ATE204300T1 (de) Zielzellen-bindende chimäre peptide
EA200300137A1 (ru) Анти-il-12-антитела, композиции, способы и применения
NZ540544A (en) Nucleic acids and proteins from streptococcus groups A & B
DE69016956D1 (de) Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor.
UA40571C2 (uk) Мутант коров'ячого вірусу герпесу типу 1 (bhv-1), композиція вакцини для вакцинації тварин для захисту їх від bhv-1, композиція вакцини для вакцинації тварин для захисту їх від патогена
EP0585257A4 (en) DNA AND AMINO ACID SEQUENCE SPECIFIC TO NATURAL K KILLER CELLS.
LU93259I2 (fr) LETIFEND (Protein Q)
SE9403526D0 (sv) New Peptides
ATE248918T1 (de) Rekombinante dnase b aus streptococcus pyogenes
ATE46703T1 (de) Regionspezifische determinanten fuer vitamin-k abhaengiges knochenprotein.
RS50013B (sr) Himerni gen koji kodira antigene determinante četiri proteina l.infantum
AP9901666A0 (en) Leishmania vaccine.
DE69737476D1 (de) Neuer galaninrezeptor
SE8502540D0 (sv) Stable dentifrice containing dextranase
ZA927199B (en) Chimeras of parainfluenza virus type 3 protein F and HN as vaccines.
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
DK292584D0 (da) Biologisk aktive konjugater, deres fremstilling og anvendelse
BR9810990A (pt) Dna-bactéria corineforme, e processos para produzir acido l-glutâmico, e, para produzir l-lisina e ácido l-glutâmico.
BR0013574A (pt) Antìgeno vacina de moraxella